Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
Total Valuation
West Pharmaceutical Services has a market cap or net worth of $16.14B. The enterprise value is $15.21B.
Market Cap$16.14B
Enterprise Value$15.21B
Share Statistics
West Pharmaceutical Services has 71,845,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding71,845,370
Owned by Insiders0.57%
Owned by Institutions24.65%
Financial Efficiency
West Pharmaceutical Services’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 14.98%.
Return on Equity (ROE)0.18
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)14.98%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee272.94K
Profits Per Employee46.48K
Employee Count10,600
Asset Turnover0.79
Inventory Turnover5.03
Valuation Ratios
The current PE Ratio of West Pharmaceutical Services is 48.53. West Pharmaceutical Services’s PEG ratio is -6.75.
PE Ratio48.53
PS Ratio0.00
PB Ratio5.76
Price to Fair Value8.91
Price to FCF49.88
Price to Operating Cash Flow23.24
PEG Ratio-6.75
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 2.89B and earned 492.70M in profits. Earnings per share was 6.75.
Revenue2.89B
Gross Profit998.50M
Operating Income569.90M
Pretax Income585.50M
Net Income492.70M
EBITDA743.80M
Earnings Per Share (EPS)6.75
Cash Flow
In the last 12 months, operating cash flow was 664.60M and capital expenditures -357.70M, giving a free cash flow of 306.90M billion.
Operating Cash Flow664.60M
Free Cash Flow306.90M
Free Cash Flow per Share4.27
Dividends & Yields
West Pharmaceutical Services pays an annual dividend of $0.827, resulting in a dividend yield of 0.37%
Dividend Per Share$0.827
Dividend Yield0.37%
Payout Ratio12.45%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.77
52-Week Price Change-29.55%
50-Day Moving Average212.11
200-Day Moving Average276.72
Relative Strength Index (RSI)62.91
Average Volume (3m)624.36K
Important Dates
West Pharmaceutical Services upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 24, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJul 30, 2025
Financial Position
West Pharmaceutical Services as a current ratio of 2.79, with Debt / Equity ratio of 11.30%
Current Ratio2.79
Quick Ratio2.11
Debt to Market Cap<0.01
Net Debt to EBITDA-0.25
Interest Coverage Ratio189.97
Taxes
In the past 12 months, West Pharmaceutical Services has paid 107.50M in taxes.
Income Tax107.50M
Effective Tax Rate0.18
Enterprise Valuation
West Pharmaceutical Services EV to EBITDA ratio is 31.90, with an EV/FCF ratio of 85.85.
EV to Sales8.20
EV to EBITDA31.90
EV to Free Cash Flow85.85
EV to Operating Cash Flow36.32
Balance Sheet
West Pharmaceutical Services has $404.20M in cash and marketable securities with $303.20M in debt, giving a net cash position of -$101.00M billion.
Cash & Marketable Securities$404.20M
Total Debt$303.20M
Net Cash-$101.00M
Net Cash Per Share-$1.41
Tangible Book Value Per Share$35.14
Margins
Gross margin is 34.59%, with operating margin of 19.70%, and net profit margin of 17.03%.
Gross Margin34.59%
Operating Margin19.70%
Pretax Margin20.24%
Net Profit Margin17.03%
EBITDA Margin25.71%
EBIT Margin20.34%
Analyst Forecast
The average price target for West Pharmaceutical Services is $274.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$274.00
Price Target Upside21.95% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-1.14%
EPS Growth Forecast-16.35%